Drug intelligence / Profile preview

Rehydragel

Development stage
Unknown
Lead developer
Chemtrade
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intramuscular, Subcutaneous
01

Overview

**Description:** Rehydragel is a highly purified, crystalline aluminum oxyhydroxide (mineralogically known as boehmite) formulated as a hydrated gel and used primarily as an adjuvant in human and veterinary vaccines[1][2][7]. It is designed to enhance the immune response by adsorbing protein antigens, thereby increasing their immunogenicity when administered with vaccines. The product has a positive charge at physiological pH, making it especially effective for binding negatively charged proteins[1]. Its high surface area (~525 m²/g) and customizable Al₂O₃ content (typically 2–10%) allow for tailored rheological properties and protein adsorption capacity[1][8]. Rehydragel does not generally induce cell-mediated immunity but promotes T-helper-2 responses with enhanced IgG1 and IgE production[2]. It is also used in blood plasma protein separation processes due to its strong protein-binding characteristics[4]. **Mechanism of Action:** As an aluminum-based adjuvant, Rehydragel works by adsorbing antigens onto its surface, facilitating their uptake by antigen-presenting cells and stimulating the humoral immune response through Th2 pathway activation. **Primary Indications:** - Adjuvant in human vaccines (e.g., HPV, pneumococcal, influenza) - Veterinary vaccine adjuvant (e.g., rabies, poultry vaccines) - Blood plasma protein separation for therapeutic applications[1][7]

Brand names
RehydragelRehydragel CGRehydragel LVRehydragel ABRehydragel HPARehydragel HSRehydragel HS 1.3Rehydragel HS 1.5Rehydragel LV-SRehydragel PMRehydragel SP
Other names
aluminum hydroxide gel (for vaccine adjuvant use)crystalline aluminum oxyhydroxide gel (boehmite)

Beyond the preview

Go deeper on Rehydragel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rehydragel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call